104266-90-2,
(S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one,
(S)-3-(3-METHYLBUTANOYL)-4-BENZYLOXAZOLIDIN-2-ONE,
(4S)-4-benzyl-3-(3-methylbutanoyl)oxazolidin-2-one,
(S)-4-BENZYL-3-(3-METHYL-BUTYRYL)-OXAZOLIDIN-2-ONE,
2-Oxazolidinone,3-(3-methyl-1-oxobutyl)-4-(phenylmethyl)-, (4S)-,
SCHEMBL2029159,
CTK4A2899,
JHGXEUXQJIKZMY-ZDUSSCGKSA-N,
0969AA,
ANW-62266,
MFCD09817644,
ZINC26522420,
AKOS016843297,
DS-3804,
AJ-82574,
AN-33930,
CJ-17497,
SC-31399,
AX8233826,
RT-015538,
4(S)-benzyl-3-isovaleroyl-oxazolidin-2-one,
AM20090803,
ST24036181,
266B902,
(S)-4-benzyl-3-(3-methylbutyryl)-2-oxazolidinone,
3-(3-Methylbutanoyl)-4beta-benzyloxazolidine-2-one,
I14-8789,
(4S)-4-benzyl-3-(3-methylbutyryl)oxazolidin-2-one,
(4S)4-Benzyl-3-(3-methylbutanoyl)oxazolidine-2-one,
2-Oxazolidinone, 3-(3-methyl-1-oxobutyl)-4-(phenylmethyl)-, (4S)-,
Copper iodide,
C15H19NO3,
CID11108107,
3-Isovaleroyl-4(S)-Benzyloxazolidin-2-one,
(4R)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one,
Aliskiren intermediate;2-Oxazolidinone, 3-(3-methyl-1-oxobutyl)-4-(phenylmethyl)-, (S)-,
1335-23-5,